General Counsel & Chief Compliance Officer · OptimizeRx Corp (OPRX)

Marion Odence-Ford

FY2021 is the first fiscal year CompBrief holds for Marion Odence-Ford as a named executive officer of OptimizeRx; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$2,478,254

Salary $251,437Stock awards $1,579,396

3rd of 3 named executive officers at OptimizeRx by FY2021 total.

3 named officers on file for OptimizeRx, FY2021

Marion Odence-Ford’s pay file — $29

  • 1 fiscal year of pay, line by line
  • OPRX’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how OptimizeRx’s whole pay program stands against its peers

  • OptimizeRx’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on OPRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 25, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Marion Odence-Ford’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Marion Odence-Ford compensation by year

OptimizeRx Summary Compensation Table · the one fiscal year held
In US dollars, as OptimizeRx reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$251,437
Bonus$0
Stock awards$1,579,396
Option awards$499,908
Non-equity incentive$139,280
Pension and deferred compensation$0
All other$8,233
Total$2,478,254

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: OptimizeRx Corp DEF 14A filed April 25, 2022, accession 0001213900-22-021416, and prior-year filings. Open the filing on EDGAR.

How this page was built: the OptimizeRx Corp filed document, accession 0001213900-22-021416. Every figure is read from that document and cited to the page and table it appears in. Filed April 25, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
RSU20,000$1,242,200—
RSU5,355$332,599—
Option10,958—$93.37

Per the Outstanding Equity Awards at Fiscal Year-End table in OptimizeRx Corp's FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

21 Form 4 lines since the FY2021 proxy (filed April 25, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-08-21Tax withholding—1,529$7.7190,407
2026-08-20Grant or award—57,600$0.00148,007
2026-02-11Tax withholding—1,386$9.2391,936
2026-02-11Exercise or conversion—4,000—93,322
2026-02-11Exercise or conversion derivative—4,000$0.000
2025-12-23Tax withholding—4,051$12.7489,322
2025-12-19Exercise or conversion—3,928$0.0094,526
2025-12-19Tax withholding—1,153$13.5193,373

The 8 most recent of 21 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

OptimizeRx’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
William FebboChief Executive Officer$14,619,576
Edward StelmakhChief Financial Officer & Chief Operating Officer$3,168,810
Marion Odence-Ford · this pageGeneral Counsel & Chief Compliance Officer$2,478,254

The full OptimizeRx compensation record

free company brief

This page is one person within OptimizeRx's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the OptimizeRx proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are OptimizeRx's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Marion Odence-Ford's compensation dossier · One-time report. No refunds.